Medindia LOGIN REGISTER
Medindia
Advertisement

Aldeyra Therapeutics to Present at the 37th Annual Canaccord Genuity Growth Conference

Thursday, August 3, 2017 General News
Advertisement
LEXINGTON, Mass., Aug. 3, 2017 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to aldehydes, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the 37th Annual Canaccord Genuity Growth Conference on Thursday, August 10, 2017.
Advertisement

Event: 37th Annual Canaccord Genuity Growth Conference Date: Thursday, August 10, 2017Time: 1:00 PM ETLocation: The InterContinental Hotel, Boston, MA
Advertisement

A live webcast of the conference call will also be available on the investor relations page of the Aldeyra Therapeutics corporate website at www.aldeyra.com. After the live webcast, the event will remain archived on the Aldeyra Therapeutics website.

About Aldeyra TherapeuticsAldeyra Therapeutics, Inc. is a biotechnology company devoted to improving lives by inventing, developing and commercializing products that treat diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules. Aldeyra's lead product candidate, ADX-102, is an aldehyde trap in development for ocular inflammation, as well as for Sjögren-Larsson Syndrome and Succinic Semi-Aldehyde Dehydrogenase Deficiency, two inborn errors of aldehyde metabolism. Aldeyra's product candidates have not been approved for sale in the U.S. or elsewhere.

Corporate Contact:Stephen TulipanoAldeyra Therapeutics, Inc.Tel: +1 781-761-4904 ext. 205 [email protected]

Investor Contact:Chris BrinzeyWestwicke PartnersTel: [email protected]

Media Contact:Cammy Duong MacDougall Biomedical Communications [email protected]

View original content:http://www.prnewswire.com/news-releases/aldeyra-therapeutics-to-present-at-the-37th-annual-canaccord-genuity-growth-conference-300498958.html

SOURCE Aldeyra Therapeutics, Inc.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close